What's breaking now, across thousands of outlets.
China has approved its first orally administered GLP-1 weight-loss drug, permitting Eli Lilly to sell its orforglipron pill in a market where 630 million adults could be overweight or obese by 2050.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
Political scientist Tõnis Leht said that the emergence of Social Democratic Party prime ministerial candidate Jonatan Vseviov has altered the dynamics among the parties' candidates for prime minister…
U.S. tech giant Nvidia Corp. has confirmed its commitment to deploying up to 260,000 graphics processing units (GPUs) in South Korea in partnership with South Korean companies, Seoul's science…
Elon Musk's SpaceX was poised Friday to carry out its latest test of the world's biggest and most powerful rocket, the Starship, with plans for a groundbreaking "catch" of the spaceship following a…
A very interesting new paper (Blondeau and Gunnell 2026) in The Journal of Environmental Management seeks to understand the evolving patterns of landslide risk in ski resorts in northern France.
A tiny asteroid entered Earth's orbit in April and is expected to leave in January. Meet the minimoon 2026 QQ8.
What does the project promise? Why are Adi community members protesting against the building of the dam? And what is the Government saying?
